167 related articles for article (PubMed ID: 38127182)
1. Structural and Biochemical Studies on Klebsiella Pneumoniae Enoyl-ACP Reductase (FabI) Suggest Flexible Substrate Binding Site.
Biswas S; Patra A; Paul P; Misra N; Kushwaha GS; Suar M
Protein J; 2024 Feb; 43(1):84-95. PubMed ID: 38127182
[TBL] [Abstract][Full Text] [Related]
2. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
3. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
[TBL] [Abstract][Full Text] [Related]
4. The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI).
Radka CD; Frank MW; Yao J; Seetharaman J; Miller DJ; Rock CO
J Biol Chem; 2020 May; 295(22):7635-7652. PubMed ID: 32317282
[TBL] [Abstract][Full Text] [Related]
5. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.
Jiang L; Gao Z; Li Y; Wang S; Dong Y
Protein Sci; 2014 Apr; 23(4):366-77. PubMed ID: 24407918
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
8. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the dimer-tetramer transition of FabI from Bacillus anthracis.
Kim HT; Kim S; Na BK; Chung J; Hwang E; Hwang KY
Biochem Biophys Res Commun; 2017 Nov; 493(1):28-33. PubMed ID: 28935372
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and structural characterization of the trans-enoyl-CoA reductase from Treponema denticola.
Bond-Watts BB; Weeks AM; Chang MC
Biochemistry; 2012 Aug; 51(34):6827-37. PubMed ID: 22906002
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
[TBL] [Abstract][Full Text] [Related]
13. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
[TBL] [Abstract][Full Text] [Related]
14. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
[TBL] [Abstract][Full Text] [Related]
15. AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.
Rao KN; Lakshminarasimhan A; Joseph S; Lekshmi SU; Lau MS; Takhi M; Sreenivas K; Nathan S; Yusof R; Abd Rahman N; Ramachandra M; Antony T; Subramanya H
Protein Sci; 2015 May; 24(5):832-40. PubMed ID: 25644789
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
Mehboob S; Truong K; Santarsiero BD; Johnson ME
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
[TBL] [Abstract][Full Text] [Related]
18. Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli.
Rafi S; Novichenok P; Kolappan S; Stratton CF; Rawat R; Kisker C; Simmerling C; Tonge PJ
J Biol Chem; 2006 Dec; 281(51):39285-39293. PubMed ID: 17012233
[TBL] [Abstract][Full Text] [Related]
19. High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.
Otero JM; Noël AJ; Guardado-Calvo P; Llamas-Saiz AL; Wende W; Schierling B; Pingoud A; van Raaij MJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1139-48. PubMed ID: 23027736
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
Lu H; Tonge PJ
Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
